has been used for rheumatoid arthritis (RA) treatment since 1980. It is the most common effective disease-modifying antirheumatic drug (DMARD) for RA, and is considered to be the anchor drug ...

ankylosing spondylitis and psoriatic arthritis, includes various conventional disease-modifying antirheumatic drugs (DMARDs). These therapeutic agents are termed DMARDs because they have the ...

Methotrexate (MTX), an older oral DMARD, remains the gold standard of treatment and is included in most combination therapy strategies. However, traditional DMARDs have a slow onset of action and ...

The efficacy and safety of leflunomide in combination with other, both nonbiologic and biologic, DMARDs have also been reviewed. 1 Leflunomide combined with methotrexate was found to be more ...

Methotrexate is a common treatment option for ... It’s called a disease-modifying antirheumatic drug (DMARD) because it reduces joint inflammation. Its initial use, dating to the late 1940s ...

There are several effective treatments for RA, including DMARDs and biologics. Both types of medications control rheumatoid arthritis by lowering the inflammation that fuels it, but there are ...

Among US veterans with rheumatoid arthritis, the use of biologic/targeted synthetic DMARDs does not appear to increase the risk of developing multiple myeloma. The use of biologic and targeted ...

Rheumatoid arthritis (RA) treatment usually includes antirheumatic drugs (DMARDs) combined with nonsteroidal anti-inflammatory drugs and low-dose steroids. Steroids are technically called ...

Methotrexate is the most commonly prescribed disease-modifying antirheumatic drug (DMARD) for rheumatoid arthritis. It causes hair loss in about 1% to 3% of patients. Methotrexate works by ...

Treatments include exercise that promotes spinal extension and mobility, NSAIDs, DMARDs (methotrexate, leflunomide and sulfasalazine), biologics (IL-17 inhibitors, TNF inhibitors, etc.) ...